glp-1 select trial Should the Make Us Comfortable Using Receptor Agonists in HFrEF? 3 Takeaways from the Landmark

It should also be noted that, from a methodological perspective, the model used (Cox with stratification by cardiovascular risk class of the trials, i.e., SURPASS-4: high risk, and all others: low risk) requires various assumptions, including the homogeneity of the relative effect of tirzepatide treatment on MACE regardless of the baseline cardiovascular risk level of the patients

The injections involve self-administering the synthetic peptide into an area with fat

Benefits of GLP-1 Medications for Weight Loss Significant Weight Loss Clinical trials have demonstrated that GLP-1 medications can lead to substantial weight loss

2009 Oct;30(10):3102-14

Red flags in the peptide market The peptide market has attracted a significant volume of unverified suppliers, particularly online

Allen JW, Mutkus L, Aschner M (2001) Methylmercury-mediated inhibition of 3H-d-aspartate transport in cultured astrocytes is reversed by the antioxidant catalase